Primary esophageal melanoma: features of diagnosis and treatment
https://doi.org/10.24884/0042-4625-2022-181-6-93-97
Abstract
Primary esophageal melanoma is a rare and extremely aggressive malignant neoplasm originating from mucosal melanocytes. The complex histological structure of the tumor, which in 10–25 % of cases may not contain melanin characteristic of these formations, leads to a high frequency of diagnostic errors, reaching 50 %. Immunohistochemical examination is the standard for diagnosing the disease. Primary esophageal melanoma is a tumor with a high potential for hematogenous and lymphogenous metastasis. So, when the tumor spreads to the submucosa, the frequency of locoregional metastasis reaches 54 %. Radical surgery in combination with adjuvant methods of treatment improves the results of treatment in this category of patients. Immunotherapy is a promising method of complex treatment, but requires further study.
About the Authors
B. V. SiguaRussian Federation
Sigua Badri V., Dr. of Sci. (Med.), Professor of the Department of Faculty Surgery named after I. I. Grekov, Head of the Clinical Oncology Center
Saint Petersburg
Competing Interests:
The authors declare no conflict of interest
S. Yu. Rakita
Russian Federation
Rakita Sergey Yu., Clinical Resident of the Department of Faculty Surgery named after I. I. Grekov
Saint Petersburg
Competing Interests:
The authors declare no conflict of interest
A. S. Kachiuri
Russian Federation
Kachiuri Andrei S., Surgeon, Oncologist of the Surgical Department № 2 of the Peter the Great Hospital
Saint Petersburg
Competing Interests:
The authors declare no conflict of interest
D. V. Gurzhy
Russian Federation
Cand. of Sci. (Med.), Head of the Surgical Department No. 2 of the Peter the Great Hospital
Saint Petersburg
Competing Interests:
The authors declare no conflict of interest
A. V. Belyaeva
Russian Federation
Belyaeva Anna V., Cand. of Sci. (Med.), Head of the Oncology Department of Anticancer Drug Therapy, Clinical Oncology Center
Saint Petersburg
Competing Interests:
The authors declare no conflict of interest
V. P. Zemlyanoy
Russian Federation
Zemlyanoy Vyacheslav P., Dr. of Sci. (Med.), Professor, Head of the Department of Faculty Surgery named after I. I. Grekov, Dean of the Faculty of Surgery
Saint Petersburg
Competing Interests:
The authors declare no conflict of interest
References
1. Sutyagin A. A., Shchelochenkov S. V., Gus’kova O. N., Shchelochenkova T. D., Bordin D. S. Primary esophageal melanoma // Effektivnaya farmakoterapiya. 2021;17(16):70–74. (In Russ.). Doi: 10.33978/23073586-2021-17-16-70-74.
2. Volchenko N. N., Mamontov A. S., Goeva N. S. Rare tumors of the esophagus // P. A. Herzen Journal of Oncology. 2019;8(6):453–459. (In Russ.). Doi: 10.17116/onkolog20198061453.
3. Sabanathan S., Eng J., Pradhan G.N. Primary malignant melanoma of the esophagus // Am J Gastroenterol. 1989;84(12):1475–1481.
4. Bisceglia M., Perri F., Tucci A., Tardio M., Panniello G., Vita G., Pasquinelli G. Primary malignant melanoma of the esophagus: a clinicopathologic study of a case with comprehensive literature review // Adv Anat Pathol. 2011;18(3):235–252. Doi: 10.1097/PAP.0b013e318216b99b.
5. Kiselev N. M., Bobrov N. V., Kuchin D. M., Torgomyan G. G., Shkalova L. V., Furman M. G., Zagainov V. E. Primary malignant melanoma of the esophagus. Literature review and clinical case // Malignant Tumours. 2019;9(4):42–48. (In Russ.). Doi: 10.18027/22245057-2019-9-4-42-48.
6. Izrailov R. E., Titov K. S., Kononets P. V., Koshkin M. A., Rotin D. L., Drapun S. V. Primary esophageal melanoma // Pirogov Russian Journal of Surgery. 2018;(5):110–111. (In Russ.). Doi: 10.17116/hirurgia20185110-111.
7. Stilidi I. S., Demidov L. V., Kononec P. V. Primary malignant melanoma of the esophagus // Rossijskij onkologicheskij zhurnal. 2003;(4):44–45. (In Russ.).
8. Petrushko N. M., Malkevich V. T., Baranov A. J. et al. Primary esophageal melanoma // Onkologicheskij zhurnal. 2017;11(1):73–78. (In Russ.).
9. Casuistic history of melanoma // Moskovskaya meditsina. 2016;1(8):65–66. (In Russ.).
10. Chen H., Fu Q., Sun K. Characteristics and prognosis of primary malignant melanoma of the esophagus // Medicine (Baltimore). 2020; 99(28):e20957. Doi: 10.1097/MD.0000000000020957.
11. Sanchez A. A., Wu T. T., Prieto V. G., Rashid A., Hamilton S. R., Wang H. Comparison of primary and metastatic malignant melanoma of the esophagus: clinicopathologic review of 10 cases // Arch Pathol Lab Med. 2008;132(10):1623–1629. Doi: 10.5858/2008-132-1623-COPAMM.
12. Volpin E., Sauvanet A., Couvelard A., Belghiti J. Primary malignant melanoma of the esophagus: a case report and review of the literature // Dis Esophagus. 2002;15:244–249. Doi: 10.1046/j.1442-2050.2002.00237.x.
13. De La Pava S., Nigogosyan G., Pickren J. W., Cabrera A. Melanosis of the esophagus // Cancer. 1963;16(1):48–50. Doi: 10.1002/1097-0142(196301)16:1<48::aid-cncr2820160107>3.0.co;2-m.
14. Bolognia J. L., Jorizzo J. L., Schaffer J. V. Dermatology. Third ed. Edinburgh: Elsevier/Saunders,2012:1075.
15. Mikkelsen L. H., Larsen A. C., von Buchwald C., Drzewiecki K. T., Prause J. U., Heegaard S. Mucosal malignant melanoma – a clinical, oncological, pathological and genetic survey // APMIS. 2016;124(6):475– 486. Doi: 10.1111/apm.12529.
16. Kumari N. S., Srujana S., Sireesha A., Krishna L., Kumar O. S. Esophageal melanocytosis – an unusual melanocytic entity // J Assoc Physicians India. 2016;64(5):75–76.
17. Ohashi K., Kato Y., Kanno J., Kasuga T. Melanocytes and melanosis of the oesophagus in Japanese subjects-analysis of factors effecting their increase // Virchows Arch. A Pathol. Anat. Histopathol. 1990;417(2):137–143. Doi: 10.1007/BF02190531.
18. Ma Y., Xia R., Ma X., Judson-Torres R.L., Zeng H. Mucosal Melanoma: Pathological Evolution, Pathway Dependency and Targeted Therapy // Front Oncol. 2021;11:702287. Doi: 10.3389/fonc.2021.702287.
19. Chang F., Deere H. Esophageal melanocytosis morphologic features and review of the literature // Arch Pathol Lab Med. 2006;130(4):552–7. Doi: 10.5858/2006-130-552-EMMFAR.
20. Fukuda S., Ito H., Ohba R., Sato Y., Ohyauchi M., Igarashi T., Obana N., Iijima K. A retrospective study, an initial lesion of primary malignant melanoma of the esophagus revealed by endoscopy // Intern. Med. 2017;56(16):2133–2137. Doi: 10.2169/internalmedicine.8378-16.
21. Sharma S. S., Venkateswaran S., Chacko A., Mathan M. Melanosis of the esophagus. An endoscopic, histochemical, and ultrastructural study // Gastroenterology. 1991;100(1):13–16. Doi: 10.1016/0016-5085(91)90576-7.
22. Ohmori T., Makuuchi H., Kumagai Y., Yamazaki K. Esophageal melanosis (in Japanese) // Shokaki Naishikyo (Endosc. Dig.). 1990;(2):1158–1159.
23. Granel Villach L., Moya Sanz M.A., Fortea Sanchis C. et al. Primary esophageal melanoma: report of a case // Rev Esp Enferm Dig. 2016;108(10):666–669. Doi: 10.17235/reed.2016.3908/2015.
24. Iwanuma Y., Tomita N., Amano T. et al. Current status of primary malignant melanoma of the esophagus: clinical features, pathology, management and prognosis // J Gastroenterol. 2012;47(1):21–28. Doi: 10.1007/s00535-011-0490-y.
25. Morita F. H., Ribeiro U. Jr., Sallum R. A. et al. Primary malignant melanoma of the esophagus: a rare and aggressive disease // World J Surg Oncol. 2013;11:210. Doi: 10.1186/1477-7819-11-210.
26. Gupta V., Kochhar R., Sinha S. K., Das A. Primary Malignant Melanoma of the Esophagus: Long-Term Survival After Radical Resection // Journal of Thoracic Oncology.2009;4(9):1180–1182. Doi: 10.1097/jto.0b013e3181a8ca9f.
27. Koga N., Kubo N., Saeki H., Sasaki S., Jogo T., Hirose K., Nakashima Y., Oki E., Koga Y., Oda Y., Oiwa H., Oiwa T., Maehara Y. Primary amelanotic malignant melanoma of the esophagus: a case report // Surg. Case Rep. 2019;5(1):4. Doi: 10.1186/s40792-019-0564-2.
28. Kobayashi J., Fujimoto D., Murakami M., Hirono Y., Goi T. A report of amelanotic malignant melanoma of the esophagus diagnosed appropriately with novel markers: A case report // Oncol Lett. 2018;15(6):9087– 9092. Doi: 10.3892/ol.2018.8479.
29. Tzung-Ju L., Tsai-Wang H., Shih-Chun L. Primary malignant melanoma of the esophagus // Ann Saudi Med. 2008;28(6):458–460. Doi: 10.5144/02564947.2008.458.
30. Jora C., Pankaj P., Verma R., Jain A., Belho E. S. Primary malignant melanoma of the esophagus // Indian J Nucl Med. 2015;30(2):162–164. Doi: 10.4103/0972-3919.152983.
31. Zhou S. L., Zhang L. Q., Zhao X. K. et al. Clinicopathological characterization of ten patients with primary malignant melanoma of the esophagus and literature review // World J Gastrointest Oncol. 2022;14(9):1739– 1757. Doi: 10.4251/wjgo.v14.i9.1739.
32. Lian B., Si L., Cui C. et al. Phase II randomized trial comparing highdose IFN-alpha2b with temozolomide plus cisplatin as systemic adjuvant therapy for resected mucosal melanoma // Clin. Cancer Res. 2013; 19(16):4488–4498. Doi: 10.1158/1078-0432.CCR-13-0739.
33. Sun H., Gong L., Zhao G. et al. Clinicopathological characteristics, staging classification, and survival outcomes of primary malignant melanoma of the esophagus // J Surg Oncol. 2018;117(4):588–596. Doi: 10.1002/jso.24905.
34. Ascierto P. A., Del Vecchio M., Mandalá M. et al. Adjuvant nivolumab versus ipilimumab in resected stage IIIB–C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, doubleblind, randomised, controlled, phase 3 trial // The Lancet Oncology. 2020;21(11):1465–1477. Doi: 10.1016/S1470-2045(20)30494-0.
Supplementary files
Review
For citations:
Sigua B.V., Rakita S.Yu., Kachiuri A.S., Gurzhy D.V., Belyaeva A.V., Zemlyanoy V.P. Primary esophageal melanoma: features of diagnosis and treatment. Grekov's Bulletin of Surgery. 2022;181(6):93-97. (In Russ.) https://doi.org/10.24884/0042-4625-2022-181-6-93-97